The letter also answers baseless assertions about AHF's connections to pharmaceutical companies: "Cipla has accused AIDS Healthcare Foundation (AHF) of working for the multi-national drug companies ... AHF, a non-government organization, vigorously opposed high drug pricing from all pharmaceutical companies. In fact, AHF has sued several drug companies over the years to lower prices ... Gilead is one company that has worked closely with AHF and is one of many supporting our free ARV programs in the developing world. Nevertheless, we are strongly opposed to Gilead's application for patents in India ... It should be clear: AHF is not for sale to anyone, at any price."
In both public news articles in India and private correspondence with AHF over the past two weeks, Cipla officials have demanded a published public apology over the advocacy advertisement. With the demand, Cipla has also informed AHF that if no apology is published within seven (7) days, then it intends to sue AHF, an international non-governmental organization (NGO) that provides direct medical care and services to over 46,000 people with HIV/AIDS in 12 countries, for USD $25 million over the ad.
In response, AHF states: "Cipla is diverting attention away from its pricing in India and smearing AHF's good name in the process. Cipla wants to intimidate the one organization that has publicly criticized it by threatening to bankrupt us by demanding a billion rupees from AHF for supposed defamation ... We will not be silenced by threats. We will continue to fight for the lives of our 60,000 patients worldwide, including those in India.
Of the 2.5 million people now estimated to be living with HIV/AIDS in
India, approximately 85,000 are receiving lifesaving antiretroviral
treatment. Cipla, the world's largest manufacturer of antiretroviral drugs
to fight HIV/AIDS (a
'/>"/>
| SOURCE AIDS Healthcare Foundation Copyright©2007 PR Newswire. All rights reserved |